Thomas Moloney
About Thomas Moloney
Thomas E. Moloney (age 81) has served as an independent director of United Parks & Resorts Inc. (PRKS) since January 2015. He is the former Senior Executive Vice President and Chief Financial Officer of John Hancock Financial Services, Inc. (1992–2004), having held prior finance roles there from 1965–1992, and briefly served as interim CFO of MSC—Medical Services Company (Dec 2007–Mar 2008). Moloney holds a B.A. in Accounting from Bentley University and an Executive Masters Professional Director Certification (Silver Level) from the American College of Corporate Directors . The Board waived its mandatory retirement age policy for Moloney through the next annual meeting in 2026 based on his experience and contributions .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| John Hancock Financial Services, Inc. | Senior Executive Vice President & CFO | 1992–2004 | Led finance; prior roles included VP, Controller, Senior Accountant (1965–1992) |
| MSC—Medical Services Company | Interim CFO | Dec 2007–Mar 2008 | Financial leadership in interim capacity |
| MSC—Medical Services Company | Director | 2005–2012 | Board service |
| Genworth Financial, Inc. | Director | 2009–2021 | Public company board service |
| Manulife International Board (Singapore) | Director | Not disclosed | Prior board service |
| Nypro, Inc. | Director | Not disclosed | Prior board service |
| 5 Star Life Insurance Company | Director | Not disclosed | Prior board service |
| Shawmut Design and Construction Company | Director | Not disclosed | Prior board service |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Nashoba Learning Group (non-profit) | Director | Current | Non-profit board |
| Boston Children’s Museum (non-profit) | Director; Past Chairperson | Current/past | Non-profit leadership |
Board Governance
- Committee assignments: Audit Committee Chair; Compensation Committee member .
- Independence: Board affirmatively determined Moloney is independent under NYSE standards; he also qualifies as an Audit Committee “financial expert” given his CFO background .
- Audit Committee activity: 2024 included 9 Audit Committee meetings; the committee’s report recommending inclusion of 2024 audited financials in the 10‑K was signed by “Thomas E. Moloney, Chair” .
- Attendance: Board held 12 meetings and committees held 41 meetings in 2024; two directors (Narang, Schaefer) were below 75% attendance; Moloney was not among those flagged .
- Retirement policy waiver: Mandatory retirement at age 75 was expressly waived for Moloney through the 2026 annual meeting, reflecting the Board’s assessment of his value to the Board .
Fixed Compensation
| Component | 2024 Amount (USD) | Notes |
|---|---|---|
| Annual cash retainer (Director) | $110,000 | Standard outside director retainer |
| Audit Committee Chair fee | $35,000 | Chair premium |
| Compensation Committee member fee | $20,000 | Committee membership |
| Special committee fee | $25,000 | Special/ad hoc service |
| Meeting fees | $0 | Meeting fee applies only if >12 meetings; Board met 12 times |
| Total cash fees | $190,000 | As reported in director compensation table |
| Election of cash vs DSUs/RSUs | 100% cash for quarterly retainer payments | Moloney elected cash for quarterly cash compensation in 2024 |
Performance Compensation
| Component | Grant Value / Detail | Vesting | Notes |
|---|---|---|---|
| Annual equity grant (DSUs/RSUs) | $219,950 (grant date fair value) | 100% vest day before next annual meeting; full vest on change-in-control | Standard $220,000 annual equity policy; Moloney reported $219,950 stock awards in 2024 |
| Clawback | Applies to awards | Reduction/forfeiture/recoupment as needed to comply with Board policy and applicable law | 2025 Omnibus Incentive Plan clawback terms |
Performance metrics table:
| Metric | Applicability | Notes |
|---|---|---|
| Financial/operating metrics (e.g., EBITDA, TSR) | Not disclosed for director equity | Non-employee director DSUs/RSUs are time-based; no specific performance metrics disclosed |
Other Directorships & Interlocks
| Company/Organization | Role | Tenure | Type |
|---|---|---|---|
| Genworth Financial, Inc. | Director | 2009–2021 | Public company |
| MSC—Medical Services Company | Director | 2005–2012 | Private company |
| Manulife International Board (Singapore) | Director | Not disclosed | Affiliate/board |
| Nypro, Inc.; 5 Star Life Insurance; Shawmut Design & Construction | Director | Not disclosed | Prior boards |
- Hill Path Capital LP holds 49.5% of PRKS shares and designates directors under a Stockholders Agreement; any material related party transactions with Hill Path require approval of a special committee of independent directors. Moloney is not identified as a Hill Path designee, mitigating direct interlock conflict risk .
Expertise & Qualifications
- Audit Committee financial expert designation based on CFO experience at John Hancock .
- Deep finance and audit oversight credentials; member of Rule 16b-3 Subcommittee alongside Maruyama for insider transaction approvals .
- Education: B.A. in Accounting (Bentley University); Professional Director Certification (Silver Level) .
Equity Ownership
| Metric | Value | Notes |
|---|---|---|
| Beneficial ownership (shares) | 34,753 | Less than 1% of outstanding shares |
| Shares outstanding (reference) | 54,966,149 | As of April 15, 2025 |
| Unvested DSUs | 4,294 | As of Dec 31, 2024; Moloney among directors holding 4,294 unvested DSUs |
| Director ownership guideline | 5x annual cash retainer | All outside directors in compliance as of Dec 31, 2024 |
| Hedging policy | Prohibited for directors | Company Securities Trading Policy prohibits hedging/monetization |
| Pledging policy | Limited; requires GC approval | Pledging restricted to approved situations |
Insider Trades
| Filing Date | Transaction Date | Type | Shares | Price | Post-transaction Ownership | SEC Link |
|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-11 | Award (A) | 617 | $0.00 | 80,995 | https://www.sec.gov/Archives/edgar/data/1564902/000095017025108307/0000950170-25-108307-index.htm |
| 2025-06-17 | 2025-06-13 | Award (A) | 5,358 | $41.06 | 80,378 | https://www.sec.gov/Archives/edgar/data/1564902/000095017025087336/0000950170-25-087336-index.htm |
| 2024-08-27 | 2024-08-23 | Award (A) | 410 | $0.00 | 75,020 | https://www.sec.gov/Archives/edgar/data/1564902/000095017024101150/0000950170-24-101150-index.htm |
| 2024-06-17 | 2024-06-13 | Award (A) | 3,884 | $0.00 | 74,610 | https://www.sec.gov/Archives/edgar/data/1564902/000095017024074222/0000950170-24-074222-index.htm |
| 2024-04-02 | 2024-03-31 | Award (A) | 75 | $0.00 | 70,726 | https://www.sec.gov/Archives/edgar/data/1564902/000095017024040114/0000950170-24-040114-index.htm |
Source: Insider-trades skill Form 4 feed for “MOLONEY THOMAS E” (director) covering 2024–2025; table shows grants and post-transaction holdings [ReadFile(/tmp/insider_trades_20251120_024554.json)].
Governance Assessment
-
Strengths
- Independent Audit Chair and designated audit financial expert; signs Audit Committee report—strong oversight signal .
- Active committee service (Audit Chair; Compensation Committee member); presence on Rule 16b-3 Subcommittee supports compliant insider transaction governance .
- Stock ownership guideline compliance and prohibitions on hedging; clawback provisions apply to awards—alignment mechanisms in place .
- Regular board and committee cadence (12 Board; 41 committee meetings in 2024) suggests robust governance processes; no attendance concerns flagged for Moloney .
-
Watch items / RED FLAGS
- Mandatory retirement age policy waiver through 2026—Board-specific exception; while justified by experience, it can raise entrenchment optics if not periodically re-evaluated .
- Concentrated shareholder (Hill Path 49.5%) maintains director designation rights; although Moloney is independent, governance environment requires continued vigilance for independence in related party matters .
- Cash election for quarterly retainer payments (100%)—modest alignment nuance; offset by significant annual equity grant and compliance with ownership guidelines .
-
Compensation structure insights
- Director compensation mix includes meaningful equity ($~220k annual DSUs/RSUs, time-based vesting) plus committee cash fees—no performance metrics for director equity, consistent with market practice; clawbacks are in place .
- Company states “No hedging or pledging Company stock,” “No excise tax gross-ups,” and “No repricing stock options without stockholder approval”—shareholder-friendly practices; note hedging prohibition and pledging limitation are policy-level .
References
- Committee memberships, independence, attendance context:
- Director compensation table and fee breakdowns:
- Equity policy, vesting, ownership guidelines:
- Beneficial ownership:
- Hedging/pledging; executive ownership guidelines:
- Clawback provisions (2025 Omnibus Plan):
- Bio, age, tenure, education, certification:
- Retirement age waiver:
- Hill Path Stockholders Agreement and governance constraints:
- Risk context on ownership concentration: